Teva divesting $1bn in assets to clear Allergan dealTeva Pharmaceutical Industries Ltd is in the process of divesting about $1 billion worth of assets to address antitrust concerns over its deal to buy Allergan Plc's generic drugs business, people familiar with the matter said. More… |
Teva divesting $1bn in assets to clear Allergan dealTeva Pharmaceutical Industries Ltd is in the process of divesting about $1 billion worth of assets to address antitrust concerns over its deal to buy Allergan Plc's generic drugs business, people familiar with the matter said. More… |
Judge blocked generic Evista launch, says LillyEli Lilly and Co has said that a federal judge issued a preliminary injunction preventing the launch of a generic version of osteoporosis drug Evista. Lilly said the action by Judge Sarah Barker of US District Court, Southern District of I More… |